Standout Papers
- Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens (2017)
- Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer (2015)
- Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study (2014)
Immediate Impact
12 by Nobel laureates 8 from Science/Nature 65 standout
Citing Papers
Therapeutic resistance to anti-oestrogen therapy in breast cancer
2023 Standout
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
Works of William T. Barry being referenced
Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer
2018
Characterization of an Oxaliplatin Sensitivity Predictor in a Preclinical Murine Model of Colorectal Cancer
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| William T. Barry | 4207 | 2320 | 1544 | 2111 | 189 | 8.2k | |
| Salomon M. Stemmer | 4877 | 1630 | 1595 | 1993 | 236 | 8.3k | |
| M. Kaufmann | 3499 | 2406 | 812 | 1624 | 241 | 6.3k | |
| Helena Earl | 3415 | 2001 | 1232 | 1871 | 191 | 6.3k | |
| Christian F. Singer | 2920 | 2002 | 954 | 1980 | 262 | 6.2k | |
| Maura N. Dickler | 6313 | 2741 | 3212 | 3363 | 164 | 10.3k | |
| Jacques De Grève | 3427 | 1256 | 1755 | 3149 | 261 | 8.1k | |
| Vesa Kataja | 3865 | 2222 | 2088 | 2308 | 174 | 8.7k | |
| Bernard Têtu | 2667 | 1437 | 2289 | 2610 | 195 | 8.2k | |
| Angelo Paradiso | 2892 | 1965 | 1022 | 3787 | 327 | 7.6k | |
| Isabella Sperduti | 3918 | 1344 | 2294 | 2138 | 391 | 8.8k |
All Works
Loading papers...